US00108J1097 - Common Stock

We assign a fundamental rating of **5** out of 10 to **ACMR**. **ACMR** was compared to 109 industry peers in the **Semiconductors & Semiconductor Equipment** industry. While **ACMR** is still in line with the averages on profitability rating, there are concerns on its financial health. **ACMR** is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!

In the past year **ACMR** had a positive cash flow from operations.

Each year in the past 5 years **ACMR** has been profitable.

In the past 5 years **ACMR** reported 4 times negative operating cash flow.

The **Return On Equity** of **ACMR** (**10.20%**) is better than **68.81%** of its industry peers.

With a decent **Return On Invested Capital** value of **8.32%**, **ACMR** is doing good in the industry, outperforming **74.31%** of the companies in the same industry.

The 3 year average ROIC (**5.41%**) for **ACMR** is below the current ROIC(**8.32%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.1% | ||

ROE | 10.2% | ||

ROIC | 8.32% |

ROA(3y)3.99%

ROA(5y)5.23%

ROE(3y)7.16%

ROE(5y)10.85%

ROIC(3y)5.41%

ROIC(5y)6.12%

With a decent **Operating Margin** value of **17.21%**, **ACMR** is doing good in the industry, outperforming **73.39%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **ACMR** has grown nicely.

Looking at the **Gross Margin**, with a value of **49.53%**, **ACMR** is in the better half of the industry, outperforming **64.22%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **ACMR** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 17.21% | ||

PM (TTM) | 12.26% | ||

GM | 49.53% |

OM growth 3Y7.77%

OM growth 5Y14.55%

PM growth 3Y4.93%

PM growth 5Y9.41%

GM growth 3Y3.67%

GM growth 5Y1.44%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **ACMR** is destroying value.

Compared to 1 year ago, **ACMR** has more shares outstanding

Compared to 5 years ago, **ACMR** has more shares outstanding

The debt/assets ratio for **ACMR** has been reduced compared to a year ago.

An Altman-Z score of **2.35** indicates that **ACMR** is not a great score, but indicates only limited risk for bankruptcy at the moment.

Looking at the **Altman-Z score**, with a value of **2.35**, **ACMR** is in line with its industry, outperforming **40.37%** of the companies in the same industry.

A Debt/Equity ratio of **0.15** indicates that **ACMR** is not too dependend on debt financing.

The **Debt to Equity ratio** of **ACMR** (**0.15**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.15 | ||

Debt/FCF | N/A | ||

Altman-Z | 2.35 |

ROIC/WACC0.64

WACC13.05%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.29 | ||

Quick Ratio | 1.26 |

Measured over the past years, **ACMR** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **55.38%** on average per year.

The **Revenue** has grown by **50.41%** in the past year. This is a very strong growth!

The **Revenue** has been growing by **49.53%** on average over the past years. This is a very strong growth!

EPS 1Y (TTM)62.99%

EPS 3Y63.93%

EPS 5Y55.38%

EPS Q2Q%14.58%

Revenue 1Y (TTM)50.41%

Revenue growth 3Y52.71%

Revenue growth 5Y49.53%

Sales Q2Q%40.05%

The **Earnings Per Share** is expected to grow by **5.94%** on average over the next years.

EPS Next Y11.78%

EPS Next 2Y9.13%

EPS Next 3Y5.94%

EPS Next 5YN/A

Revenue Next Year35.96%

Revenue Next 2Y28.23%

Revenue Next 3Y23.48%

Revenue Next 5Y21.48%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

Based on the **Price/Earnings** ratio, **ACMR** is valued cheaply inside the industry as 97.25% of the companies are valued more expensively.

The average S&P500 **Price/Earnings** ratio is at **31.73**. **ACMR** is valued rather cheaply when compared to this.

With a **Price/Forward Earnings** ratio of **10.99**, the valuation of **ACMR** can be described as very reasonable.

93.58% of the companies in the same industry are more expensive than **ACMR**, based on the **Price/Forward Earnings** ratio.

The average S&P500 **Price/Forward Earnings** ratio is at **22.71**. **ACMR** is valued rather cheaply when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.3 | ||

Fwd PE | 10.99 |

93.58% of the companies in the same industry are more expensive than **ACMR**, based on the **Enterprise Value to EBITDA** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 7.84 |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

The decent profitability rating of **ACMR** may justify a higher PE ratio.

PEG (NY)0.87

PEG (5Y)0.19

EPS Next 2Y9.13%

EPS Next 3Y5.94%

No dividends for **ACMR**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**ACM RESEARCH INC-CLASS A**

NASDAQ:ACMR (10/14/2024, 8:11:41 PM)

After market: 21.4112 +0.08 (+0.38%)**21.33**

**+0.01 (+0.05%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.33B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.3 | ||

Fwd PE | 10.99 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.87

PEG (5Y)0.19

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.1% | ||

ROE | 10.2% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 17.21% | ||

PM (TTM) | 12.26% | ||

GM | 49.53% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.42

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.15 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.29 | ||

Quick Ratio | 1.26 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)62.99%

EPS 3Y63.93%

EPS 5Y

EPS Q2Q%

EPS Next Y11.78%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)50.41%

Revenue growth 3Y52.71%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y